HIGHLIGHTS
- who: Junmeng Li from the University of Nevada, United States have published the research: Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from 18F fluorodeoxyglucose PET/CT images in gastric cancer, in the Journal: (JOURNAL)
- what: The authors aimed to develop a PET/CT image based radiomics signature of tumor immune microenvironment and to assess the ability of this signature to predict survival and adjuvant chemotherapy benefits. The authors found that adjuvant chemotherapy provided a better survival benefit to patients with stage II and III GC patients classified as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.